SPECIALIST METHOD DEVELOPMENT / VISIBLE PARTICLE CONTROL
When the product or container limits particle visibility, the preparation route matters. We develop and validate product-specific methods for supplemental and, where appropriate, destructive testing.
What can be examined — and what must be recovered?
Opaque, coloured, viscous, suspended or lyophilized products can limit direct observation. The study begins with the product state, container, sampling origin and the analytical question, rather than a universal instrument sequence.
Study-selected units, products after reconstitution or resuspension, inspection findings and recovered defects can require different handling. Not every recovered defect originates from a routine 100% inspection reject.
Select the route that preserves analytical meaning
Reconstitution and resuspension
Controlled product-specific preparation may reveal particles that were obscured in the original product state. Document the preparation and any effects on the particles.
Investigate a recovered visible defect
Direct particle isolation
Where suitable, isolate newly visible particles directly, using needle isolation or micromanipulation. Record the defect before and after recovery and assess possible handling effects.
Sieving and selective recovery
Select recovery steps around the matrix and particle characteristics. Sieving or other selective recovery may be appropriate; preparation losses and possible material changes require evaluation.
Filtration where suitable
Filtration is one possible collection step, not a mandatory route. Neither filtration nor automated counting is required for every recovered visible defect.
Demonstrate suitability for the intended use
Preparation blanks, recovery, matrix effects and possible particle alteration or loss are addressed through method development. Analytical validation uses an agreed protocol and acceptance criteria suited to the product and endpoint.
Documented microscopy, selected-particle Raman results and suitable reference comparisons can support a forensic investigation of the recovered defect. Interpret the finding in its original sampling and inspection context.
Explore the shared Foreign Particle Investigation service
Regulatory and methodological context
USP <1790>, USP <790>, EU GMP Annex 1 and the nonbinding PDA TR 79 provide relevant inspection and supplemental-testing context. ICH Q14 and Q2(R2) inform intended-use-based analytical development and validation. Supplemental testing does not automatically replace required visual inspection; an informational reference is not a universal preparation mandate.
Visible particle defects and investigations
Subvisible particle characterization
Parenteral programme overview
Discuss a difficult-to-inspect product
Describe the product state, container and particle question. We can define an appropriate feasibility and method-development scope.
Discuss your project